Results of treatment of pituitary disease in multiple endocrine neoplasia, type I

Neurosurgery

Volumn 39, Issue 2, 1996, Pages 273-279

  O'Brien, Timothy ^a   O'Riordan, Diarmuid S ^a   Gharib, Hossein ^a   Scheithauer, Bernd W ^a   Ebersold, Michael J ^a   Van Heerden, Jon A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acromegaly; Macroadenoma; Prolactinoma; Transsphenoidal surgery

Indexed keywords

ACROMEGALY; ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HORMONE RELEASE; HUMAN; HYPERPARATHYROIDISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; PROGNOSIS; PROLACTINOMA; TREATMENT OUTCOME;

ACROMEGALY; ADENOMA; ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHYSECTOMY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARANEOPLASTIC ENDOCRINE SYNDROMES; PITUITARY GLAND; PITUITARY IRRADIATION; PITUITARY NEOPLASMS; PROLACTINOMA; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029973786     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199608000-00008     Document Type: Article

References (30)

1. Bahn RS, Scheithauer BW, van Heerden JA, Laws ER Jr, Horvath E, Gharib H: Nonidentical expressions of multiple endocrine neoplasia, Type I, in identical twins. Mayo Clin Froc 61:689-696, 1986.
2. Ballard HS, Frame B, Hartsock RJ: Familial multiple endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 43:481-516, 1964.
3. Benson L, Ljunghall S, Akerstrom G, Oberg K: Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia Type 1. Am J Med 82:731-737, 1987.
4. Bergstralh EJ, Offord KP: Conditional probabilities used in calculating cohort expected survival, in Technical Report Series No. 37, Medical Research Statistics. Rochester, Mayo Clinic, 1988.
5. Blackwell RE: Hyperprolactinemia: Evaluation and management. Endocrinol Metab Clin North Am 21:105-124, 1992.
6. Bone HG III: Diagnosis of the multiglandular endocrine neoplasias. Clin Chem 36:711-718, 1990.
7. Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA: Familial multiple endocrine neoplasia Type I: A new look at pathophysiology. Endocr Rev 8:391-405, 1987.
8. Davis DH, Laws ER Jr, Ilstrup DM, Speed JK, Caruso M, Shaw EG, Abboud CF, Scheithauer BW, Root LM, Schleck C: Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg 79:70-75, 1993.
9. Goldman M, Holub D: Prolactinomas and the multiple endocrine adenomatosis Type-1 complex. Ann Intern Med 91:791-792, 1979 (letter).
10. Grisoli F, Leclercq T, Jaquet P, Guibout M, Winteler JP, Hassoun J, Vincentelli F: Transsphenoidal surgery for acromegaly: Long-term results in 100 patients. Surg Neurol 23:513-519, 1985.
11. Hershon KS, Kelly WA, Shaw CM, Schwartz R, Bierman EL: Prolactinomas as part of the multiple endocrine neoplastic syndrome Type 1. Am J Med 74:713-720, 1983.
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
13. Klibanski A, Zervas NT: Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 324:822-831, 1991.
14. Kovacs K, Horvath E: Pathology of pituitary adenomas. Bull Los Angeles Neurol Soc 42:92-110, 1977.
15. Kovacs K, Horvath E: Pituitary adenomas: Pathologic aspects, in Tolis G, Labrie F, Martin JB (eds): Clinical Neuroendocrinology: A Pathophysiological Approach. New York, Raven Press, 1979.
16. Lamers CBHW, Froeling PGAM: Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis Type I (MEA I). Am J Med 66:422-424, 1979.
17. Larsson C, Nordenskjold M: Multiple endocrine neoplasia. Cancer Surv 9:703-723, 1990.
18. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M: Multiple endocrine neoplasia Type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 322:85-87, 1988.
19. Marx SJ, Vinik AI, Santen RJ, Floyd JC Jr, Mills JL, Green J III: Multiple endocrine neoplasia Type I: Assessment of laboratory tests to screen for the gene in a large kindred. Medicine (Baltimore) 65:226-241, 1986.
20. Mathew CGP, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI, Fong S-L, Bridges CDB, Haak H, Kruseman ACN, Schifter S, Hansen HH, Telenius H, Telenius-Berg M, Ponder BAJ: A linked genetic marker for multiple endocrine neoplasia Type 2A on chromosome 10. Nature 328:527-528, 1987.
21. Molitch ME: Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am 21:866-901, 1992.
22. Oberg K, Skogseid B, Eriksson B: Multiple endocrine neoplasia Type 1 (MEN-1): Clinical, biochemical and genetical investigations. Acta Oncol 28:383-387, 1989.
23. Peto R, Peto J: Asymptotically efficient rank invariant procedures. J R Stat Soc (A) 135:185-207, 1972.
24. Randall RV, Laws ER Jr, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW: Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas: Results in 100 patients. Mayo Clin Proc 58:108-121, 1983.
25. Rizzoli R, Green J III, Marx SJ: Primary hyperparathyroidism in familial multiple endocrine neoplasia Type I: Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med 78:467-474, 1985.
26. Robert F: Electron microscopy of human pituitary tumors, in Tindall GT, Collins WF (eds): Clinical Management of Pituitary Disorders. New York, Raven Press, 1979, p 113.
27. Ross DA, Wilson CB: Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurg 68:854-867, 1988.
28. Scheithauer BW, Laws ER Jr, Kovacs K, Horvath E, Randall RV, Carney JA: Pituitary adenomas of the multiple endocrine neoplasia Type I syndrome. Semin Diagn Pathol 4:205-211, 1987.
29. Vieto RJ, Hickey RC, Samaan NA: Type 1 multiple endocrine neoplasias. Curr Probl Cancer 7:1-25, 1982.
30. Wynne AG, Gharib H, Scheithauer BW, Davis DH, Freeman SL, Horvath E: Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients. Am J Med 92:15-24, 1992.